A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make ...

Access free, up-to-date clinical references about the risk factors of HER2-positive breast cancer. Healio's Clinical Guidance content provides valuable insights for physicians.

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

Groundbreaking new treatment for aggressive breast cancer has 100% survival rate By . Reda Wigle. Published May 30, 2025, 9:18 a.m. ET.